🇺🇸 Hydroxyethyl Starch in United States

42 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bradycardia — 7 reports (16.67%)
  2. Pneumonia — 6 reports (14.29%)
  3. Drug Ineffective — 5 reports (11.9%)
  4. Cardiac Failure — 4 reports (9.52%)
  5. Febrile Neutropenia — 4 reports (9.52%)
  6. Hypokalaemia — 4 reports (9.52%)
  7. Deafness Bilateral — 3 reports (7.14%)
  8. Dizziness — 3 reports (7.14%)
  9. Electrolyte Imbalance — 3 reports (7.14%)
  10. Exposure During Pregnancy — 3 reports (7.14%)

Source database →

Hydroxyethyl Starch in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Hydroxyethyl Starch approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hydroxyethyl Starch in United States?

Hospital de Cruces is the originator. The local marketing authorisation holder may differ — check the official source linked above.